Utrophin-glycoprotein complex (UGC) (UGC)

The utrophin-glycoprotein complex (UGC) is a multi-protein assembly located at the sarcolemma of muscle cells, serving as a functional autosomal homolog to the dystrophin-glycoprotein complex (DGC) (UniProt P46939). It consists of the large scaffold protein utrophin and several associated proteins, including alpha- and beta-dystroglycans, sarcoglycans, dystrobrevin, and syntrophins, which together link the intracellular actin cytoskeleton to the extracellular matrix (Davies & Nowak, 2006). In healthy adult muscle, the UGC is primarily localized to the neuromuscular and myotendinous junctions; however, in the absence of dystrophin—as seen in Duchenne muscular dystrophy (DMD)—the UGC can be upregulated and redistributed along the entire sarcolemma to provide structural stability (Fairclough et al., 2013). Therapeutic strategies targeting this complex focus on pharmacological "utrophin modulation" to increase its expression, thereby compensating for the lack of dystrophin and preventing muscle fiber necrosis (Muntoni et al., 2019). While drugs like ezutromid have been explored in clinical trials, achieving sufficient and sustained upregulation remains a significant challenge in the field of neuromuscular medicine (Ricotti et al., 2016). Consequently, the UGC is considered a universal target for DMD, potentially benefiting all patients regardless of their specific dystrophin gene mutation.

Other names

Utrophin-associated protein complexUAPCUtrophin-dystroglycan complexUtrophin-associated glycoprotein complex

Utrophin upregulation via transcriptional activation or mRNA stabilization; recruitment of utrophin to the sarcolemma to functionally replace missing dystrophin.